TRANSCODE THERAPEUTICS

TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. Our lead therapeutic candidate, that we believe has blockbuster potential, targets an RNA molecule which has been shown to be the driver of metastatic disease across multiple tumor types and has been validated pre-clinically in our lab at MGH. Our initial FIH clinical study, for which an eIND filing is planned for Q1 of 2022, is intended to provide positive proof-of-mechanism for the TTX platform.

TRANSCODE THERAPEUTICS

Social Links:

Industry:

Biotechnology Health Care Therapeutics

Founded:

2016-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.transcodetherapeutics.com

Total Employee:

Status:

Active

Total Funding:

1.1 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics

Similar Organizations

arkuda-therapeutics-logo

Arkuda Therapeutics

Arkuda Therapeutics is a pharmaceutical company.

cerebral-therapeutics-logo

Cerebral Therapeutics

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

oric-pharmaceuticals-logo

ORIC Pharmaceuticals

ORIC Pharmaceuticals operates as a biopharmaceutical company.

Current Employees Featured

r-michael-dudley_image

R. Michael Dudley
R. Michael Dudley Co-Founder,President & CEO @ Transcode Therapeutics
Co-Founder,President & CEO
2015-01-01

philippe-p-calais_image

Philippe P. Calais
Philippe P. Calais Director @ Transcode Therapeutics
Director
2018-11-01

tom-fitzgerald_image

Tom Fitzgerald
Tom Fitzgerald Chief Financial Officer @ Transcode Therapeutics
Chief Financial Officer

zdravka-medarova_image

Zdravka Medarova
Zdravka Medarova Chief Technology Officer @ Transcode Therapeutics
Chief Technology Officer
2021-10-01

Founder

r-michael-dudley_image

R. Michael Dudley

zdravka-medarova_image

Zdravka Medarova

Stock Details

Company's stock symbol is NASDAQ:RNAZ

Investors List

national-cancer-institute_image

Key Employee Changes

Date	New article
2021-09-30	TransCode Therapeutics Appoints Zdravka Medarova, Ph.D., as Chief Technology Officer

Official Site Inspections

http://www.transcodetherapeutics.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.59 K

Host Informations
Whois Informations

Loading ...